Correlation Between Telix Pharmaceuticals and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals Limited and HUTCHMED DRC, you can compare the effects of market volatilities on Telix Pharmaceuticals and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and HUTCHMED DRC.

Diversification Opportunities for Telix Pharmaceuticals and HUTCHMED DRC

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Telix and HUTCHMED is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and HUTCHMED DRC

Considering the 90-day investment horizon Telix Pharmaceuticals Limited is expected to generate 0.75 times more return on investment than HUTCHMED DRC. However, Telix Pharmaceuticals Limited is 1.33 times less risky than HUTCHMED DRC. It trades about 0.09 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.01 per unit of risk. If you would invest  1,515  in Telix Pharmaceuticals Limited on September 16, 2024 and sell it today you would earn a total of  61.00  from holding Telix Pharmaceuticals Limited or generate 4.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy33.85%
ValuesDaily Returns

Telix Pharmaceuticals Limited  vs.  HUTCHMED DRC

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Telix Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Telix Pharmaceuticals and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and HUTCHMED DRC

The main advantage of trading using opposite Telix Pharmaceuticals and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind Telix Pharmaceuticals Limited and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data